OP0201
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for OP0201, covering 2019-12-30 to 2020-08-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months [Phase 2]